1Salvati F, Rasi G, Portalone L, et al. Combined treatment with thymosin-alphal and low-dose interferon-alpha after ifosfamide in non-small cell lung cancer: a phase-II controlled trial. Anticancer Res, 1996,16 : 1001-1004.
2Maio M, Mackiewicz A, Testori A, et al. Large randomized study of thymosin alpha 1, interferon alfa, or both in combination with dacarbazine in patients with metastatic melanoma. J Clin Oncol, 2010,28 : 1780-1787.
3Li C, Bo L, Liu Q, et al. Thymosin alphal based immunomodulatory therapy for sepsis: a systemmatic review and meta-analysisEJl. Int J Infect Dis,2015,33:90-96.
4Dalm VA, de Wit H, Drexhage HA. Thymosinctl: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis[J]. Ann N Y Acad Sci,2012,1270:1-7.
